This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 04:35, 22 August 2011 (Updating {{drugbox}} (no changed fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validation|Chem/Dru). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 04:35, 22 August 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (no changed fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validation|Chem/Dru)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundVaccine description | |
---|---|
Target | Rubella |
Vaccine type | Attenuated |
Clinical data | |
ATC code | |
(verify) |
Rubella vaccine is a vaccine used against rubella. One form is called "Meruvax".
See also
References
- Josefson D (2001). "Rubella vaccine may be safe in early pregnancy". BMJ. 322 (7288): 695. PMC 1119900. PMID 11264203.
{{cite journal}}
: Unknown parameter|month=
ignored (help) - Weibel RE, Caserta V, Benor DE, Evans G (1998). "Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program". Pediatrics. 101 (3 Pt 1): 383–7. doi:10.1542/peds.101.3.383. PMID 9481001.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link)
Artificial induction of immunity / Immunization: Vaccines, Vaccination, Infection, Inoculation (J07) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Development | |||||||||||
Classes | |||||||||||
Administration | |||||||||||
Vaccines |
| ||||||||||
Inventors/ researchers | |||||||||||
Controversy | |||||||||||
Related | |||||||||||
|